T43.01 Poisoning by, adverse effect of and underdosing of tricyclic antidepressants

Name of the Condition

• Poisoning by, adverse effect of and underdosing of tricyclic antidepressants
• Technical term: T43.01

Summary

This code covers conditions related to tricyclic antidepressants (TCAs), including poisoning, adverse effects, or underdosing. TCAs are a class of medications used to treat depression, anxiety, and other mental health conditions. The code is applied when the outcome (poisoning, adverse effect, or underdosing) is associated with TCAs and not classified elsewhere.

Causes

Poisoning or adverse effects may result from accidental or intentional overdose, incorrect dosing, or an abnormal reaction to the drug. Underdosing can occur due to prescription errors, patient non-adherence, or economic barriers to obtaining full medication supplies. Adverse effects are caused by the body's response to the drug, which may vary by individual.

Risk Factors

• History of substance use or misuse.
• Concurrent use of multiple medications that interact with TCAs.
• Pre-existing conditions affecting drug metabolism (e.g., liver or kidney disease).
• Lack of access to healthcare or medication guidance.

Symptoms

Symptoms depend on the outcome but may include:

• Altered mental status, confusion, or sedation.
• Nausea, vomiting, or gastrointestinal distress.
• Changes in heart rate or blood pressure.
• Dry mouth, blurred vision, or urinary retention.
• Worsening of depressive symptoms (in underdosing).

Diagnosis

Diagnosis involves patient history, medication review, and clinical assessment. For poisoning or adverse effects, clinicians evaluate symptoms and potential drug exposure. Underdosing is identified through adherence discussions and medication supply checks. Lab tests or electrocardiograms may be used to assess toxicity or metabolic impact.

Treatment Options

Treatment depends on the outcome:

• Poisoning: Decontamination, supportive care, and monitoring for complications.
• Adverse effects: Dose adjustment, alternative medications, or symptom management.
• Underdosing: Education on proper dosing, addressing barriers to adherence, or adjusting prescriptions.

Prognosis and Follow-Up

Prognosis varies by outcome. Poisoning may require intensive care, while adverse effects often resolve with dose changes. Underdosing outcomes improve with adherence support. Follow-up ensures symptom resolution and medication safety.

Complications

• Severe poisoning can lead to cardiac arrhythmias, seizures, or respiratory depression.
• Chronic underdosing may result in persistent depression or treatment failure.
• Adverse effects may cause long-term discomfort or require discontinuation of the drug.

Lifestyle & Prevention

• Use medication organizers to avoid missed doses.
• Store TCAs securely to prevent accidental or intentional overdose.
• Communicate openly with healthcare providers about side effects or adherence challenges.
• Avoid mixing TCAs with alcohol or other sedatives.

When to Seek Professional Help

Seek immediate care for symptoms of poisoning (e.g., confusion, irregular heartbeat) or severe adverse effects. Contact a provider for persistent depressive symptoms or concerns about medication adherence.

Tips for Medical Coders

Document the specific outcome (poisoning, adverse effect, or underdosing) and confirm the drug is a tricyclic antidepressant. Ensure clinical notes support the chosen outcome to justify code assignment.